David Soergel sold $517K of MDGL stock

David Soergel, Chief Medical Officer of Madrigal Pharmaceuticals, Inc. (MDGL), sold 1,042 shares of MDGL stock worth $517K, per an SEC Form 4 filed Jun 1, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Jun 1, 2026.

MDGL has moved -10.1% since the trade date, from $481.23 to $432.79 (Nov 9, 2026 close).